Literature DB >> 12531697

Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFbeta family.

Véronique Maguer-Satta1, Laurent Bartholin, Sandrine Jeanpierre, Martine Ffrench, Sylvie Martel, Jean-Pierre Magaud, Ruth Rimokh.   

Abstract

Activin A, BMP2, and BMP4, members of the TGFbeta family, have been implicated in the regulation of hematopoiesis. Here we explore and compare, for the first time in human primary cells, the role of activin A, BMP2, and BMP4 during erythropoiesis. Using in vitro erythroid differentiation of CD34(+) primary cells, we obtained the main stages of early erythropoiesis, characterized at the molecular, biochemical, and functional levels. Our results indicate that BMP2 acts on early erythroid cells and activin A on a more differentiated population. We report an insight into the mechanism of commitment of erythropoiesis by activin A and BMP2 involving two key events, increase in EPO-R and decrease in GATA2 expression. Simultaneous addition of activin A with BMP molecules suggests that BMP2 and BMP4 differently affect activin A induction of erythropoiesis. Follistatin and FLRG proteins downmodulate the effects of activin A and BMP2 on erythroid maturation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531697     DOI: 10.1016/s0014-4827(02)00013-7

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  28 in total

Review 1.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 2.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

Review 3.  The role of GATA2 in lethal prostate cancer aggressiveness.

Authors:  Veronica Rodriguez-Bravo; Marc Carceles-Cordon; Yujin Hoshida; Carlos Cordon-Cardo; Matthew D Galsky; Josep Domingo-Domenech
Journal:  Nat Rev Urol       Date:  2016-11-22       Impact factor: 14.432

4.  Decreased "ineffective erythropoiesis" preserves polycythemia in mice under long-term hypoxia.

Authors:  Tomonori Harada; Isao Tsuboi; Yukio Hirabayashi; Kazuhiro Kosaku; Michiko Naito; Hiroyuki Hara; Tohru Inoue; Shin Aizawa
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

5.  Activins and follistatins: Emerging roles in liver physiology and cancer.

Authors:  Emanuel Kreidl; Deniz Oztürk; Thomas Metzner; Walter Berger; Michael Grusch
Journal:  World J Hepatol       Date:  2009-10-31

Review 6.  Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production.

Authors:  Laura Breda; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 7.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

8.  Bone morphogenetic protein-2/4 signalling pathway components are expressed in the human thymus and inhibit early T-cell development.

Authors:  Teresa Cejalvo; Rosa Sacedón; Carmen Hernández-López; Blanca Diez; Cruz Gutierrez-Frías; Jaris Valencia; Agustín G Zapata; Alberto Varas; Angeles Vicente
Journal:  Immunology       Date:  2007-05       Impact factor: 7.397

Review 9.  The role of TGFβ in hematopoiesis and myeloid disorders.

Authors:  Alex Bataller; Guillermo Montalban-Bravo; Kelly A Soltysiak; Guillermo Garcia-Manero
Journal:  Leukemia       Date:  2019-02-28       Impact factor: 11.528

10.  GAGE: generally applicable gene set enrichment for pathway analysis.

Authors:  Weijun Luo; Michael S Friedman; Kerby Shedden; Kurt D Hankenson; Peter J Woolf
Journal:  BMC Bioinformatics       Date:  2009-05-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.